Kura Oncology, Inc. (KURA) Stock Overview
NASDAQ · Healthcare · Biotechnology
✓ Sourced directly from Yahoo Finance · Checked for accuracy at every rebuild · Snapshot: 6 September 2026
About Kura Oncology, Inc.
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer. The company's first commercial product, KOMZIFTI (ziftomenib), a potent, selective, reversible and oral small molecule menin inhibitor; Darlifarnib, a Phase 1 first-in-human FIT-001…
Source: Yahoo Finance
Sector & Industry
Kura Oncology, Inc. operates in the Healthcare sector, within the Biotechnology industry group. It is listed on the NASDAQ exchange.
Kura Oncology, Inc. at a Glance
| Company | Kura Oncology, Inc. |
| Ticker | KURA |
| Exchange | NASDAQ |
| Currency | USD |
| Price | $13.25 |
| Market cap | $1.18B |
| P/E ratio (trailing) | — |
| EPS (trailing) | -$3.37 |
| 52-week high | $13.90 |
| 52-week low | $7.36 |
| Dividend yield | — |
| Ex-dividend date | — |
| Beta | 0.43 |
| Return on equity (ROE) | -167.71% |
| Debt-to-equity | 50.49% |
| Average volume | 1.79M |
| Shares outstanding | 88.96M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 260 |
| Country | United States |
Investing Essentials
As an Amazon Associate we earn from qualifying purchases. Links below are affiliate links.
Peter Lynch on how everyday investors can spot winners before the professionals do.
Check Price →Benjamin Graham's classic on value investing — the book Warren Buffett calls the best ever written on the subject.
Check Price →Evaluating pharma pipelines, devices and healthcare economics.
Check Price →Frequently Asked Questions
- What is Kura Oncology, Inc.'s current P/E ratio?
- Kura Oncology, Inc. (KURA) has a trailing P/E ratio of — as of our 6 September 2026 data snapshot. Learn what the P/E ratio means →
- What is Kura Oncology, Inc.'s market capitalisation?
- Kura Oncology, Inc.'s market cap is $1.18B based on our latest snapshot. See how it ranks by market cap →
- What is KURA's 52-week range?
- Over the past 52 weeks, KURA has traded between $7.36 and $13.90. What does the 52-week range mean? →
- How volatile is Kura Oncology, Inc. compared to the market?
- Kura Oncology, Inc. has a beta of 0.43, meaning it has historically moved less than the broader market. What does beta measure? →
- Does Kura Oncology, Inc. pay a dividend?
- Kura Oncology, Inc. does not currently pay a dividend according to our latest data.
- What exchange is KURA listed on?
- KURA is listed on the NASDAQ. Browse all NASDAQ-listed stocks →
- What sector is Kura Oncology, Inc. in?
- Kura Oncology, Inc. is classified in the Healthcare sector. Compare with Healthcare peers →
For compound interest, percentage change and other investing maths, try our free online calculators.
Many readers keep a stock investing journal to log positions and theses alongside pages like this one, and a dedicated financial calculator to hand for quick valuation maths.
Recommended Reading & Tools
Philip Fisher on what makes a business worth owning for the long term.
Check Price →Morgan Housel's short lessons on behaviour, luck and long-term wealth.
Check Price →Burton Malkiel's evidence-based guide to markets, indexing and long-term strategy.
Check Price →